(Q53198044)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Alexander Spiel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Leitner JM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jilma B

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Mayr FB

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Firbas C

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Rathgen K

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Stähle H

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Schühly U

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Graefe-Mody EU

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

4 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

858-866

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

Response of man to endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Pharmacogenetics of acenocoumarol pharmacodynamics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Pharmacokinetics and pharmacodynamics of BIBT 986, a novel small molecule dual inhibitor of thrombin and factor Xa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Coagulation interventions in experimental human endotoxemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Heparin blunts endotoxin-induced coagulation activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Platelet function predicts myocardial damage in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Effects of carbon monoxide inhalation during experimental endotoxemia in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Monitoring of anticoagulant effects of direct thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Effects of anticoagulation on thrombopoietin release during endotoxemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100153

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410124%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference